State-wise Status of Multi-Drug Resistant (MDR)/ Rifampicin Resistant (RR) with Additional Resistance Patients Diagnosis and Treatment under National Tuberculosis Elimination Programme (NTEP) in Northern States of India (2020) | |||||||||
States/UTs | MDR/RR With Additional Resistance Diagnosed | FQ/SLI/InhA/Z Resistance Patients Initiated on Treatment (Other than XDR) | FQ/SLI/InhA/Z Resistance Patients Initiated on Longer Oral Regimen (Other than XDR) | ||||||
FQ Resistance | SLI Resistance | InhA Resistance | Z Resistance | FQ/SLI/InhA/Z Resistance Detected (Other than XDR) | |||||
No. | %age | No. | %age | ||||||
Chandigarh | |||||||||
Delhi | |||||||||
Haryana | |||||||||
Himachal Pradesh | |||||||||
Jammu & Kashmir | |||||||||
Ladakh | |||||||||
Punjab | |||||||||
Rajasthan | |||||||||
Uttar Pradesh | |||||||||
Uttarakhand | |||||||||
Northern India | |||||||||
India |